Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

SPARC-like 1/SPARCL1 Antibody (204), mFluor Violet 450 SE, Novus Biologicals™
SDP

Catalog No. NB308293 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB308293 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB308293 Supplier Novus Biologicals Supplier No. NBP289236MFV450
Only null left
Add to Cart
Add to Cart

Rabbit Monoclonal Antibody

SPARC-like 1/SPARCL1 Monoclonal antibody specifically detects SPARC-like 1/SPARCL1 in Human samples. It is validated for ELISA

Specifications

Antigen SPARC-like 1/SPARCL1
Applications ELISA
Classification Monoclonal
Clone 204
Conjugate mFluor Violet 450 SE
Dilution ELISA
Formulation 50mM Sodium Borate
Gene Alias hevin, High endothelial venule protein, MAST 9, MAST9, PIG33, proliferation-inducing protein 33, SC1, SPARC-like 1 (hevin), SPARC-like 1 (mast9, hevin), SPARC-like protein 1
Host Species Rabbit
Immunogen This antibody was obtained from a rabbit immunized with purified, recombinant Human SPARC-like 1/SPARCL1 (Accession#: NP_004675.3; Met 1-Phe 664).
Purification Method Protein A purified
Quantity 0.1 mL
Regulatory Status RUO
Research Discipline Cancer
Primary or Secondary Primary
Gene ID (Entrez) 8404
Target Species Human
Content And Storage Store at 4C in the dark.
Form Purified
Isotype IgG
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.